Monday, November 25, 2024

US expansion for York lateral flow test manufacturer

York Biotech Campus-based Abingdon Health is expanding in the US after signing a lease to open a commercial office and laboratory in Madison, Wisconsin.

The site will commence operations in October 2024 and is expected to become fully operational in early 2025. This US footprint will enable Abingdon to provide additional CDMO (contract development and manufacturing organisation) support to its broadening international customer base and be closer to large customers in North America.

The USA is the largest medical device market in the world, comprising over 40% of the global medtech market and containing over 6,500 medtech companies. 30% of Abingdon’s revenues in the last financial year were derived from the United States.

The Group’s newly incorporated wholly owned subsidiary, Abingdon Health USA Inc, will operate from the University Research Park in Madison, Dane County, Wisconsin.

Chris Yates, CEO of Abingdon Health plc, said: “I’m looking forward to driving Abingdon’s worldwide commercial activities and, in particular, expanding our customer base in the US, the largest med-tech market globally.

“Our laboratory site in the US will mean we can offer US customers the opportunity to buy their services in the US; this is a first step for Abingdon to provide a broader CDMO proposition from within the US market.”

Lisa Johnson, CEO of BioForward Wisconsin, said: “On behalf of the biohealth community in Wisconsin, we welcome Abingdon Health to Madison. Abingdon Health is a leader in lateral flow diagnostic technology with a unique, end-to-end value proposition for its customers.

“As a publicly-traded UK company with a global presence, their decision to open a US office here in Wisconsin provides yet more evidence of our state’s growing stature in personalized medicine and biohealth technologies.

“We look forward to Abingdon Health complementing and strengthening our biohealth ecosystem, and bringing more economic impact and jobs to Wisconsin.”

A message from the Editor:

Thank you for reading this story on our news site - please take a moment to read this important message:

As you know, our aim is to bring you, the reader, an editorially led news site and magazine but journalism costs money and we rely on advertising, print and digital revenues to help to support them.

With the Covid-19 pandemichaving a major impact on our industry as a whole, the advertising revenues we normally receive, which helps us cover the cost of our journalists and this website, have been drastically affected.

As such we need your help. If you can support our news sites/magazines with either a small donation of even £1, or a subscription to our magazine, which costs just £31.50 per year, (inc p&P and mailed direct to your door) your generosity will help us weather the storm and continue in our quest to deliver quality journalism.

As a subscriber, you will have unlimited access to our web site and magazine. You'll also be offered VIP invitations to our events, preferential rates to all our awards and get access to exclusive newsletters and content.

Just click here to subscribe and in the meantime may I wish you the very best.








Latest news

Related news